MultiPlan Current Deferred Revenue from 2010 to 2025
| MPLN Stock | USD 19.44 2.92 17.68% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 575.5 M | Current Value 511.6 M | Quarterly Volatility 34.8 M |
Check MultiPlan financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MultiPlan's main balance sheet or income statement drivers, such as Interest Expense of 314.2 M, Ebit of 150.8 M or Interest Income of 11.7 M, as well as many indicators such as Price To Sales Ratio of 74.05, Dividend Yield of 0.0 or PTB Ratio of 35.62. MultiPlan financial statements analysis is a perfect complement when working with MultiPlan Valuation or Volatility modules.
MultiPlan | Current Deferred Revenue |
Pair Trading with MultiPlan
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MultiPlan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MultiPlan will appreciate offsetting losses from the drop in the long position's value.Moving together with MultiPlan Stock
Moving against MultiPlan Stock
| 0.8 | HCAT | Health Catalyst | PairCorr |
| 0.7 | XAIR | Beyond Air | PairCorr |
| 0.57 | NRC | National Research Corp | PairCorr |
| 0.5 | VMD | Viemed Healthcare | PairCorr |
| 0.46 | JYNT | Joint Corp | PairCorr |
The ability to find closely correlated positions to MultiPlan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MultiPlan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MultiPlan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MultiPlan to buy it.
The correlation of MultiPlan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MultiPlan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MultiPlan moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MultiPlan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of MultiPlan Correlation against competitors. To learn how to invest in MultiPlan Stock, please use our How to Invest in MultiPlan guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MultiPlan. If investors know MultiPlan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MultiPlan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (95.28) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of MultiPlan is measured differently than its book value, which is the value of MultiPlan that is recorded on the company's balance sheet. Investors also form their own opinion of MultiPlan's value that differs from its market value or its book value, called intrinsic value, which is MultiPlan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MultiPlan's market value can be influenced by many factors that don't directly affect MultiPlan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MultiPlan's value and its price as these two are different measures arrived at by different means. Investors typically determine if MultiPlan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MultiPlan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.